Drug-class-wide resistance (DCWR) to antiretrovirals substantially reduces treatment options.

Tozzi, V., Zaccarelli, M., Bonfigli, S., Lorenzini, P., Liuzzi, G., Trotta, M., et al. (2006). Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome. ANTIVIRAL THERAPY, 11(5), 553-560.

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome

BERTOLI, ADA;PERNO, CARLO FEDERICO;
2006-01-01

Abstract

Drug-class-wide resistance (DCWR) to antiretrovirals substantially reduces treatment options.
2006
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA
English
Con Impact Factor ISI
Treatment Failure; HIV Protease Inhibitors; Humans; Salvage Therapy; Antiviral Agents; Reverse Transcriptase Inhibitors; Viral Load; Genotype; HIV Infections; Risk Factors; Adult; Cohort Studies; Antiretroviral Therapy, Highly Active; Drug Resistance, Multiple, Viral; HIV; Time Factors; Mutation; Female; Male
PMID: 16964822
Tozzi, V., Zaccarelli, M., Bonfigli, S., Lorenzini, P., Liuzzi, G., Trotta, M., et al. (2006). Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome. ANTIVIRAL THERAPY, 11(5), 553-560.
Tozzi, V; Zaccarelli, M; Bonfigli, S; Lorenzini, P; Liuzzi, G; Trotta, M; Forbici, F; Gori, C; Bertoli, A; Bellagamba, R; Narciso, P; Perno, Cf; Antin...espandi
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons Creative Commons

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/26922
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact